Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.28% Nasdaq 0.00%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS

88.49 Up 0.02(0.02%) Jun 21, 4:00PM EDT|After Hours : 88.70 Up 0.21 (0.24%) Jun 21, 7:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 338,941   320,526   294,136   274,719  
Cost of Revenue35,269  33,147  (20,191)31,613  
Gross Profit 303,672   287,379   314,327   243,106  
Operating Expenses
Research Development74,536  63,409  54,280  59,635  
Selling General and Administrative108,826  112,624  89,957  94,855  
Non Recurring3,234  3,365  27,267  4,807  
Others104  105  104  104  
Total Operating Expenses186,700  179,503  171,608  159,401  
Operating Income or Loss 116,972   107,876   142,719   83,705  
Income from Continuing Operations
Total Other Income/Expenses Net940  575  (99)96  
Earnings Before Interest And Taxes117,912  108,451  142,620  83,801  
Interest Expense1,171  1,182  1,854  2,079  
Income Before Tax116,741  107,269  140,766  81,722  
Income Tax Expense34,524  26,298  48,586  45,464  
Minority Interest -   -   -   -  
Net Income From Continuing Ops82,217  80,971  92,180  36,258  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 82,217   80,971   92,180   36,258  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 82,217   80,971   92,180   36,258  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.